Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Empagliflozin
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
GREEN
Empagliflozin
(For heart failure)
Cardiovascular system, Heart Failure, 02.05.05
GREEN
Empagliflozin
(For patients with Type 2 diabetes)
Endocrine system, SGLT2 inhibitors, 06.01.02.03
Empagliflozin
(For Chronic kidney disease)
Obstetrics, Gynaecology, and urinary-tract disorders, Other preparations for urinary disorders, 07.04.03
Canagliflozin
(For Chronic kidney disease WITH Type 2 diabetes)
Obstetrics, Gynaecology, and urinary-tract disorders, Other preparations for urinary disorders, 07.04.03
Dapagliflozin
(For Chronic kidney disease)
Obstetrics, Gynaecology, and urinary-tract disorders, Other preparations for urinary disorders, 07.04.03
GREEN
Ertugliflozin Steglatro
®
(For patients with Type 2 diabetes)
Endocrine system, SGLT2 inhibitors, 06.01.02.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Empagliflozin
Empagliflozin
Cardiovascular System, Heart Failure, Blood Glucose Lowering Drugs Sodium Glucose Co-Transporter 2 Inhibitors
Empagliflozin
Empagliflozin
Endocrine System, Diabetes Mellitus And Hypoglycaemia, Diabetes Mellitus, Blood Glucose Lowering Drugs Sodium Glucose Co-Transporter 2 Inhibitors
Empagliflozin
Empagliflozin
Genito-Urinary System, Kidney Disorders, Blood Glucose Lowering Drugs Sodium Glucose Co-Transporter 2 Inhibitors
Empagliflozin
Empagliflozin With Linagliptin
Endocrine System, Diabetes Mellitus And Hypoglycaemia, Diabetes Mellitus, Blood Glucose Lowering Drugs Dipeptidylpeptidase-4 Inhibitors (Gliptins)
Empagliflozin
Empagliflozin With Linagliptin
Endocrine System, Diabetes Mellitus And Hypoglycaemia, Diabetes Mellitus, Blood Glucose Lowering Drugs Sodium Glucose Co-Transporter 2 Inhibitors
Empagliflozin
Empagliflozin With Metformin
Endocrine System, Diabetes Mellitus And Hypoglycaemia, Diabetes Mellitus, Blood Glucose Lowering Drugs Biguanides
Empagliflozin
Empagliflozin With Metformin
Endocrine System, Diabetes Mellitus And Hypoglycaemia, Diabetes Mellitus, Blood Glucose Lowering Drugs Sodium Glucose Co-Transporter 2 Inhibitors
Links found
BLMK ICB Guidance for General Practitioners to support prescribing of Empagliflozin (Jardiance®) for children and young people under 18 years with Type 2 Diabetes (T2DM)
NICE TA1006: Empagliflozin for treating type 2 diabetes in people 10 to 17 years (terminated appraisal)
NICE TA336 : Empagliflozin in combination therapy for treating type 2 diabetes
NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes
NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes
NICE TA773: Empagliflozin for treating chronic heart failure with reduced ejection fraction
NICE TA929: Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction